AHCRN Registry: Characterizing Patient Populations in the Adult Hydrocephalus Clinical Research Network (AHCRN)
The AHCRN Registry has been developed to obtain data about hydrocephalus patientevents, treatments and outcomes from the network Clinical Centers, and to create a database to be used by AHCRN investigators. The ongoing maintenance of the Registry serves two main purposes: (1) it will help investigators understand the variability, progression, and current treatment practices for hydrocephalus in adults, with an ultimate goal of better guiding and assessing therapeutic intervention and providing recommendations on patient care and; (2) it will provide pilot and descriptive data necessary for hypothesis generation and study design (e.g., preliminary power analyses, recruitment projections) for studies under development by the AHCRN. This multi-institutional database will be useful for tracking trends in hydrocephalus over time. The Registry will be an invaluable resource to the AHCRN and will help stimulate new research protocols, identify potential need for future expansion of the network to incorporate additional patient populations, and provide a descriptive understanding of adults with hydrocephalus cared for within the network.
AIDS-Related Lymphoma | NYU Langone Health
Doctors at Perlmutter Cancer Center provide expert care for people who have AIDS-related lymphoma, a group of cancers that begin in white blood cells.
Airway Abnormality Services for Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone offer advanced diagnostic tools and treatments for airway abnormalities in children.
Airway Center | NYU Langone Health
NYU Langone’s Airway Center provides evaluation and treatment for adults and children with upper airway problems.
Airway Center Doctors | NYU Langone Health
Find a doctor at the Airway Center at NYU Langone.
Airway Clearance for Nontuberculous Mycobacterial Infections | NYU Langone Health
NYU Langone doctors may recommend techniques to prevent mucus building up in the lungs from a nontuberculous mycobacterial infection.
Airway Clearance Techniques for Cystic Fibrosis in Children | NYU Langone Health
Experts at NYU Langone provide ongoing support and education on airway clearance techniques to treat cystic fibrosis in children.
Airway Monitoring for Cystic Fibrosis in Children | NYU Langone Health
Doctors at NYU Langone regularly monitor people with cystic fibrosis for signs of lung infections.
Airway, Breathing & Lung Conditions | NYU Langone Health
NYU Langone doctors specialize in treating infections and diseases of the lungs, including asthma, bronchitis, chronic cough, and lung cancer.
AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients with Advanced Solid Tumors with AKT1 E17K Mutation
This trial is designed to test the effectiveness of ALTA2618 in patients with advanced solid tumors that have a specific genetic mutation (AKT1 E17K). The study is divided into two parts: Phase 1, where the dose of ALTA2618 will be increased to find the maximum safe dose, and Phase 1b, where the drug will be tested in different groups of patients with specific types of cancer, like HR+/HER2-negative breast cancer and gynecological cancers. The trial will also look at how the drug works in the body (pharmacokinetics), its effect on the tumor, and how safe it is at different doses. In Phase 1, patients will receive the drug once daily, and the dose will be adjusted based on the safety and effectiveness data collected during the study. If patients show positive results, they may continue treatment even after the disease progresses. The study will continue until the best dose and treatment schedule are determined for further testing in Phase 2 trials.